Searchable abstracts of presentations at key conferences on calcified tissues

ba0005p347 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

Development of Korean Fracture Risk Score predicting osteoporotic fracture risk: analysis of data from the Korean National Health Insurance Service

Kim Ha-Young , Jang Eun-Jin , Park Byeong Ju , Ha Y-C , Jang Sunmee

Background: Asian-specific prediction model for estimating the individual risk of osteoporotic fracture was rare. We aimed to develop a Korean fracture risk prediction model using clinical risk factors and assess external validity of the final model.Methods: A total of 718,306 Korean men and women aged 50–90 were followed for 7 years in national system based cohort study. Fifty percent were randomly assigned to the development dataset and 50% to the...

ba0005p359 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

Glucocorticoid acts differently on vertebral and hip fractures in Korean RA patients using National healthcare claims database

Kim Dam , Cho Soo-Kyung , Park Byeongju , Jang Eun Jin , Bae Sang-Cheol , Sung Yoon-Kyoung

Background and objectives: Fracture in rheumatoid arthritis (RA) patient is more frequent than general population. One of the important reasons is use of glucocorticoid (GC) for treatment of RA. In this study, we aimed to identify the effect of GC on fracture of different site.Methods: Among RA patients ≧19 years, we established a retrospective cohort using Korean national healthcare claims database from Jan 2010 to Dec 2010, and then followed up unti...

ba0005p385 | Osteoporosis: treatment | ECTS2016

The effect of teriparatide on fracture healing of vertevral compression fracture in postmenopausal women

Young Park Si , Woo Suh Seung , Young Hong Jae , Rae Kim Jung

Introduction: Acute vertebral compression fractures cause severe back pain and need long time to heal. The progression of fracture or nonunion is not rare. The teriparatide is a synthetic parathyroid hormone which has been used as anabolic agent and treatment of osteoporosis. It can also be used for promoting fracture healing in special condition. Periodic infusion of teriparatide enhances bone formation and increases bone strength. We evaluated the effect of periodic teripara...

ba0005p391 | Osteoporosis: treatment | ECTS2016

Prevalence of osteoporosis and effectiveness of screening test using ultrasound bone densitometry and education in a community-dwelling population

Ha Yong-Chan , Kim Deog-Yoon , Lee Young-Kyun , Cho Eun-Hee , Kwon Gi-Doo

Background: In 2004, we reported a 48.1% prevalence of osteoporosis in an Ibansung cohort. The current prospective intervention study was undertaken in order to estimate the prevalence of osteoporosis from 2004 to 2015 and the increasing treatment rate of osteoporosis following osteoporosis screening tests with ultrasound bone densitometry and education in the same cohort.Methods: From November 1, 2014 to August 31, 2015, 960 adults ≥50 years of ag...

ba0005p436 | Other diseases of bone and mineral metabolism | ECTS2016

Determinants of health related quality of life in adults with osteogenesis imperfecta

Hald Jannie Dahl , Folkestad Lars , Harslof Torben , Brixen Kim , Langdahl Bente

Osteogenesis imperfecta (OI) is a systemic connective tissue caused by mutations in collagen type 1 related genes. Patients with OI suffer from multiple fractures and various degrees of growth deficiency and bone deformity. Other symptoms are early hearing loss, abnormal dental tissue and hypermobility. It is not known whether the systemic effect of a defect collagen type 1 influences the quality of life in people with OI. We aimed to investigate health related quality of life...

ba0006oc21 | (1) | ICCBH2017

Scoliosis in fibrous dysplasia/McCune-albright syndrome

Berglund Jason , Tella Sri Harsha , Kim Lauren , Stanton Robert , Collins Michael , Boyce Alison

Objectives: Fibrous dysplasia is a rare bone and endocrine disorder resulting from somatic activating mutations in GNAS. In the skeleton, proliferation of undifferentiated stromal cells results in osseous lesions that are prone to deformity, fracture, and pain. Lesions may affect one bone or many, and may occur in isolation or in association with hyperfunctioning endocrinopathies, termed McCune-Albright syndrome (MAS). Scoliosis is a potentially serious, even lethal c...

ba0006p064 | (1) | ICCBH2017

Extensive periosteal new bone formation secondary to copper deficiency in a 2 year-old boy with arterial tortuosity syndrome

Bowden Sasigarn , Adler Brent , Shaikhkhalil Ala , Hor Kan , McBride Kim , Steingass Katherine

Background: Periosteal reaction can be a manifestation of various underlying medical conditions, including tumor, infection, trauma, metabolic or genetic diseases.Presenting problem: A 2 year-old male presented for evaluation of periosteal bone formation in symmetrical distribution of proximal humerus, radius, ulnar, femur, and clavicles, noted after having persistent fussiness, irritability and inability to bear weight and use arms for 3 weeks. He had a...

ba0003pp357 | Osteoporosis: treatment | ECTS2014

In postmenopausal women previously treated with an oral bisphosphonate and at higher risk of fracture, denosumab significantly increases bone mineral density compared with ibandronate and risedronate

Brown Jacques P , Bolognese Michael A , Ho Pei-Ran , Roux Christian , Bone Henry G , Bonnick Sydney L , van den Bergh Joop , Ferreira Irene , Ghelani Prayashi , Dakin Paula , Wagman Rachel B , Recknor Christopher

Low bone mineral density (BMD) is an important and modifiable risk factor for fracture in postmenopausal women with osteoporosis. Denosumab (DMAb) shows a stronger relationship between BMD increases and antifracture efficacy than oral bisphosphonate (BP) therapies. Subjects who remain at higher risk of fracture despite current BP therapy need treatment. In two studies, DMAb significantly increased BMD and decreased bone turnover markers vs a BP (ibandronate (IBN) or risedronat...

ba0007p121 | (1) | ICCBH2019

An Acvr1[R258G] ‘conditional on' mouse model of atypical fibrodysplasia ossificans progressiva (FOP) is Activin A dependent

Huang Lily , Schoenherr Chris , Wang Lili , Wen Xialing , McClain Joyce , Zhang Qian , Nannuru Kalyan , Idone Vincent , Murphy Andrew , Economides Aris , Hatsell Sarah

FOP is an autosomal dominant disorder characterized by early onset, episodic and progressive ossification of skeletal muscle and associated connective tissue. FOP is driven by mutations in the intracellular domain of ACVR1 (ALK2), the most common of which is R206H. However, rare FOP causing mutations exist throughout the GS and the kinase domain of Acvr1. Several of these mutations result what appears to be a more severe FOP phenotype that includes significant developmental ab...